NewAmsterdam Pharma Company NV
F:KH6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NewAmsterdam Pharma Company NV
F:KH6
|
NL |
|
Morguard Corp
F:74S
|
CA |
|
K
|
Krakatau Steel (Persero) Tbk PT
IDX:KRAS
|
ID |
|
S
|
Singapore Telecommunications Ltd
F:SIT4
|
SG |
|
K
|
Kering SA
XHAM:PPX
|
FR |
|
R
|
Republic Services Inc
XBER:RPU
|
US |
|
C
|
Canada One Mining Corp
XTSX:CONE
|
CA |
|
A
|
Altria Group Inc
DUS:PHM7
|
US |
|
S
|
Societe Generale SA
XMUN:SGE
|
FR |
|
S
|
Sumitomo Corp
SWB:SUMA
|
JP |
|
TOC Co Ltd
F:T3O
|
JP |
|
B
|
BHP Group Ltd
XMUN:BHP
|
AU |
|
T
|
technotrans SE
DUS:TTR1
|
DE |
|
C
|
Compass Group PLC
OTC:CMPGY
|
UK |
|
Sofina SA
XBRU:SOF
|
BE |
|
B
|
Basf Se
BET:BASF
|
DE |
|
LiveOne Inc
F:3510
|
US |
|
Dassault Systemes SE
F:DSYA
|
FR |
|
T
|
Terumo Corp
DUS:TUO
|
JP |
|
R
|
Rolls-Royce Holdings PLC
F:RRU
|
UK |
Bankruptcy Probability
NewAmsterdam Pharma Company NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
NewAmsterdam Pharma Company NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
3.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
435B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
NewAmsterdam Pharma Company NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, NewAmsterdam Pharma Company NV has total debt of 23k EUR. This includes both short-term (0 EUR) and long-term (23k EUR) debt.
You can find a full breakdown on its Balance Sheet.
